首页 | 本学科首页   官方微博 | 高级检索  
检索        

酪酸梭菌联合四联疗法治疗幽门螺杆菌阳性胃溃疡的作用机制研究
引用本文:白芳芸,郑红英,冯雅宁,辛瑞娟,酒梦娜,白飞虎.酪酸梭菌联合四联疗法治疗幽门螺杆菌阳性胃溃疡的作用机制研究[J].中国现代医学杂志,2017,27(9):83-86.
作者姓名:白芳芸  郑红英  冯雅宁  辛瑞娟  酒梦娜  白飞虎
作者单位:1.宁夏医科大学总医院 VIP科,宁夏 银川 750004;2.宁夏回族自治区人民医院 消化内科,宁夏 银川 750001;3.宁夏医科大学 研究生院,宁夏 银川750004
基金项目:

宁夏回族自治区自然科学基金(No:81360323)

摘    要:

摘要:目的  观察酪酸梭菌(Cb)联合四联疗法治疗幽门螺杆菌(Hp)阳性胃溃疡的作用。方法  选取Hp阳性胃溃疡102例,采取随机双盲方法,将其分为观察组和对照组。前2周,观察组口服埃索美拉唑镁肠溶片+枸橼酸铋剂钾片+阿莫西林胶囊+左氧氟沙星片+酪酸梭菌活菌胶囊,对照组在上述四联疗法基础上加空白胶囊;后2周,停用抗生素和枸橼酸铋剂钾片。疗程结束后1个月,比较两组治疗有效率、Hp根除率、不良反应发生率。结果  观察组有效率为89.46%,对照组为76.00%,经χ2检验,差异无统计学意义(P >0.05)。观察组HP根除率为82.69%,对照组HP为64.00%,经χ2检验,差异有统计学意义(P <0.05)。观察组不良反应发生率为11.54%,对照组为18.00%,经χ2检验,差异无统计学意义(P >0.05)。结论  Cb联合四联疗法能够提高胃溃疡Hp根除率。



关 键 词:

幽门螺旋杆菌  胃溃疡  酪酸梭菌  四联疗法

收稿时间:2016/3/25 0:00:00

Effect of Clostridium butyricum combined with quadruple therapy on Helicobacter pylori-positive gastric ulcer
Fang-yun Bai,Hong-ying Zheng,Ya-ning Feng,Rui-juan Xin,Meng-na Jiu,Fei-hu Bai.Effect of Clostridium butyricum combined with quadruple therapy on Helicobacter pylori-positive gastric ulcer[J].China Journal of Modern Medicine,2017,27(9):83-86.
Authors:Fang-yun Bai  Hong-ying Zheng  Ya-ning Feng  Rui-juan Xin  Meng-na Jiu  Fei-hu Bai
Institution:1. Department of VIP, General Hospital of Ningxia Medical University, Yinchuan, Ningxia 750004, China; 2. Department of Gastroenterology, the People''s Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia 750001, China; 3. Graduate School, Ningxia Medical University, Yinchuan, Ningxia 750004, China
Abstract:

Abstract: Objective To observe the effect of Clostridium butyricum joint quadruple therapy on Helicobacter pylori-positive gastric ulcer. Methods A total of 102 cases with H. pylori-positive gastric ulcer were selected. Adapting randomized double-blind method, they were divided into observation group and control group. In the first 2 weeks, the patients in the observation group were treated with a quadruple therapy (Esomeprazole + Bismuth Potassium Citrate + Amoxicillin + Levofloxacin) combined with Clostridium capsules; while those in the control group received the same quadruple therapy plus blank capsules. After 2 weeks, bismuth potassium citrate  and antibiotics were stopped. The treatment efficiency, H. pylori eradication rate, and incidence of adverse reactions were compared between the two groups 1 month after treatment. Results The effective percentage was 89.46% in the observation group and 76.00% in the control group, the difference was not statistically significant (P > 0.05). The eradication rate of H. pylori was 82.69% in the observation group, while 46.00% in the control group, the difference was statistically significant (P < 0.05). The incidence of adverse reactions was 11.54% in the observation group and 18.00% in the control group, the difference was not statistically significant (P > 0.05). Conclusions Clostridium combined with quadruple therapy can increase the eradication rate of H. pylori in gastric ulcer.

Keywords:

   Helicobacter pylori  gastric ulcer  Clostridium butyricum  quadruple therapy

点击此处可从《中国现代医学杂志》浏览原始摘要信息
点击此处可从《中国现代医学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号